This final article summarises some of the presentations of SABCS 2024 that did not fit in the categories discussed earlier. Firstly, a retrospective study assessed the impact of risk-reducing surgeries on survival in BRCA carriers with a prior history of breast cancer at a young age. Furthermore, the PRO B trial evaluated the effect of alert-based patient-reported outcome (PRO) monitoring on symptom control and physical functioning. Subsequently, an EBCTCG analysis assessed the association of overweight and obesity with cancer outcomes in patients with early-stage breast cancer (EBC). Finally, the BWEL trial studied the impact of weight loss intervention on inflammatory and metabolic biomarkers in obese patients with EBC.